- Home
- CGTX vs SPAI Comparison
CGTX vs SPAI Comparison
Compare CGTX & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- SPAI
- Stock Information
- Founded
- CGTX 2007
- SPAI 2021
- Country
- CGTX United States
- SPAI United States
- Employees
- CGTX N/A
- SPAI N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- SPAI Industrial Specialties
- Sector
- CGTX Health Care
- SPAI Health Care
- Exchange
- CGTX Nasdaq
- SPAI Nasdaq
- Market Cap
- CGTX 126.2M
- SPAI 139.4M
- IPO Year
- CGTX 2021
- SPAI 2024
- Fundamental
- Price
- CGTX $1.70
- SPAI $6.98
- Analyst Decision
- CGTX Strong Buy
- SPAI Strong Buy
- Analyst Count
- CGTX 3
- SPAI 2
- Target Price
- CGTX $2.83
- SPAI $10.50
- AVG Volume (30 Days)
- CGTX 3.3M
- SPAI 368.0K
- Earning Date
- CGTX 11-12-2025
- SPAI 11-13-2025
- Dividend Yield
- CGTX N/A
- SPAI N/A
- EPS Growth
- CGTX N/A
- SPAI N/A
- EPS
- CGTX N/A
- SPAI N/A
- Revenue
- CGTX N/A
- SPAI $1,496,091.00
- Revenue This Year
- CGTX N/A
- SPAI N/A
- Revenue Next Year
- CGTX N/A
- SPAI $1,027.49
- P/E Ratio
- CGTX N/A
- SPAI N/A
- Revenue Growth
- CGTX N/A
- SPAI 7.49
- 52 Week Low
- CGTX $0.22
- SPAI $1.47
- 52 Week High
- CGTX $3.83
- SPAI $9.16
- Technical
- Relative Strength Index (RSI)
- CGTX 52.47
- SPAI 52.76
- Support Level
- CGTX $1.29
- SPAI $6.21
- Resistance Level
- CGTX $1.61
- SPAI $7.96
- Average True Range (ATR)
- CGTX 0.14
- SPAI 0.74
- MACD
- CGTX -0.01
- SPAI -0.08
- Stochastic Oscillator
- CGTX 93.62
- SPAI 43.57
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About SPAI Safe Pro Group Inc. Common Stock
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.